WO2017037743A3 - Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form - Google Patents

Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form Download PDF

Info

Publication number
WO2017037743A3
WO2017037743A3 PCT/IN2016/050290 IN2016050290W WO2017037743A3 WO 2017037743 A3 WO2017037743 A3 WO 2017037743A3 IN 2016050290 W IN2016050290 W IN 2016050290W WO 2017037743 A3 WO2017037743 A3 WO 2017037743A3
Authority
WO
WIPO (PCT)
Prior art keywords
crystal form
dabigatran etexilate
salt
butanedisulfonate
butanedisulfonate salt
Prior art date
Application number
PCT/IN2016/050290
Other languages
French (fr)
Other versions
WO2017037743A2 (en
Inventor
Rajamannar Thennati
Shriprakash Dhar DWIVEDI
Kanaksinh Jesingbhai Jadav
Vijaykumar Muljibhai Patel
Rutvij Manharlal Bhatt
Original Assignee
Sun Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Limited filed Critical Sun Pharmaceutical Industries Limited
Publication of WO2017037743A2 publication Critical patent/WO2017037743A2/en
Publication of WO2017037743A3 publication Critical patent/WO2017037743A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

The present invention provides a 1:1 salt of dabigatran etexilate with 1,4-butanedisulfonic acid, its crystal form and process for its preparation.
PCT/IN2016/050290 2015-09-03 2016-09-02 Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form WO2017037743A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3391MU2015 2015-09-03
IN3391/MUM/2015 2015-09-03

Publications (2)

Publication Number Publication Date
WO2017037743A2 WO2017037743A2 (en) 2017-03-09
WO2017037743A3 true WO2017037743A3 (en) 2018-09-27

Family

ID=58186977

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2016/050290 WO2017037743A2 (en) 2015-09-03 2016-09-02 Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form

Country Status (1)

Country Link
WO (1) WO2017037743A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305665A1 (en) * 2005-06-04 2011-04-06 Boehringer Ingelheim International GmbH Polymorphs of 3-[(2-{[4-(hexyloxy carbonyl amino-imino-methyl)-phenyl amino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propion acid-ethyl ester
CN103864756A (en) * 2012-12-11 2014-06-18 四川海思科制药有限公司 Butanedisulfonic acid dabigatran etexilate and preparation method and application thereof
WO2015124764A1 (en) * 2014-02-24 2015-08-27 Erregierre S.P.A. Synthesis process of dabigatran etexilate mesylate, intermediates of the process and novel polymorph of dabigatran etexilate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305665A1 (en) * 2005-06-04 2011-04-06 Boehringer Ingelheim International GmbH Polymorphs of 3-[(2-{[4-(hexyloxy carbonyl amino-imino-methyl)-phenyl amino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propion acid-ethyl ester
CN103864756A (en) * 2012-12-11 2014-06-18 四川海思科制药有限公司 Butanedisulfonic acid dabigatran etexilate and preparation method and application thereof
WO2015124764A1 (en) * 2014-02-24 2015-08-27 Erregierre S.P.A. Synthesis process of dabigatran etexilate mesylate, intermediates of the process and novel polymorph of dabigatran etexilate

Also Published As

Publication number Publication date
WO2017037743A2 (en) 2017-03-09

Similar Documents

Publication Publication Date Title
IL285739A (en) Salts, crystal forms, and production methods thereof
HRP20181698T1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
ZA201808503B (en) Diorganylphosphinic acid salts, method for the production thereof and the use thereof
EP3325608A4 (en) Methods and microorganisms for the production of 1,3-butanediol
EP3498836A4 (en) Production method for l-amino acid
EP3508684A4 (en) Method for treating the near-wellbore region of a formation
MX2016017127A (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids.
WO2014141292A3 (en) Endoxifen citrate polymorph and process for preparing the same
EP3452084A4 (en) Anti-kv1.3 antibodies, and methods of production and use thereof
IN2014MU00675A (en)
EP3222624A4 (en) Imidic acid compound having divalent anion and process for producing the same
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
EP3444244A4 (en) Preparation process for high-purity dabigatran etexilate
EP3447042A4 (en) Manufacturing method of 1,2-dichlorohexafluorocyclopentene
EP3193610A4 (en) Selective nav1.7 inhibitors for the treatment of diabetes
EP3473616A4 (en) Novel pyridonecarboxylic acid derivative or salt thereof
WO2017037743A3 (en) Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form
MY174415A (en) Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof
WO2016126006A8 (en) Microorganism capable of producing quinolinic acid, and method for producing quinolinic acid utilizing the microorganism
EP3177592A4 (en) Process for the preparation of 4,5,6-trichloropicolinic acid
WO2016040313A3 (en) Methods of treating cancer comprising administering a ppar-gamma agonist
MX2016005220A (en) Acid dyes, process for the production thereof and their use.
MX2016005222A (en) Acid dyes, process for the production thereof and their use.
EP3510016A4 (en) Process for the production of n-boc-2-amino-3,3-dimethylbutyric acid

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16841008

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16841008

Country of ref document: EP

Kind code of ref document: A2